Main Page: Difference between revisions

Safer nicotine wiki Tobacco Harm Reduction
Jump to navigation Jump to search
No edit summary
No edit summary
Line 38: Line 38:
reviewed articles on  
reviewed articles on  


(1) [[nicotine therapeutic benefits]];
(1) [[nicotine therapeutic benefits]],
(2) [[safer nicotine vape/snus smoking cessation efficacy,]]  
(2) [[safer nicotine vape/snus smoking cessation efficacy,]]  
(3) safer nicotine impact on  
(3) safer nicotine impact on  
       (a) [[cancer risk,]]  
       (a) [[cancer risk,]]  
       (b) [[lung health,]]  
       (b) [[lung health,]]  
(c) [[cardiovascular health.]]
(c) [[cardiovascular health.]]

Revision as of 20:30, 30 November 2020

Library image

MediaWiki has been installed.

Consult the User's Guide for information on using the wiki software.

Please if Anyone has a idea submit your requests for edit access to richard@pruen.co.uk

Admins are listed on the user page Special:ListUsers

This Wiki has been assembled by a team of keen volunteers, free from any funding from any source. It is the intention to assemble a wide ranging collection of the most relevant and widely cited papers relating to Vaping,E-cigarettes,and all Safer Nicotine Products eg Snus. It would not be a credible source unless positive and negative studies are both included,provided well conducted,bias and propaganda free. Hopefully, a unique feature that will make this wiki a person-friendly experience, is that highly technical papers and studies will receive a vastly simplified, unbiased summary of one or two paragraphs maximum, in simple to understand language. We hope you both enjoy and appreciate the efforts of the volunteers.


        • Putting this here jico as a reminder****

ideally want current (in last month) impactful study section in a prominent place towards the beginning to attract attention , whether split +ve /-ve is unimportant

Then to the main body of the reports with subdivisions eg (folks need to add to this hastily assembled list) nicotine, safety, statistics ie population studies and modelling, alternative safer nicotine products, moral case

      • more bits to just put here for now***

NASEM

RCP

PHE

CRUK FAQ

ASH FAQ 1

ASH FAQ 2

reviewed articles on

(1) nicotine therapeutic benefits,

(2) safer nicotine vape/snus smoking cessation efficacy,

(3) safer nicotine impact on

      (a) cancer risk, 
      (b) lung health, 

(c) cardiovascular health.